Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11400-11405
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11400
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11400
Figure 1 Overall efficacy of 15 mg/d tolvaptan.
Overall efficacy of 15 mg/d tolvaptan for 5-14 d in all patients as well as in subgroups of patients with coexisting hepatocellular carcinoma (HCC) and hepatorenal syndrome (HRS) post-tolvaptan treatment.
- Citation: Zhang X, Wang SZ, Zheng JF, Zhao WM, Li P, Fan CL, Li B, Dong PL, Li L, Ding HG. Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients. World J Gastroenterol 2014; 20(32): 11400-11405
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11400.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11400